Palmitamide MEA
Also known as: N-Palmitoylethanolamine, PEA, Cetyl-PG Hydroxyethyl Palmitamide, Palmitoylethanolamide
Description
Palmitamide MEA (palmitoylethanolamide / N-palmitoylethanolamine) is an endogenous fatty acid amide belonging to the N-acylethanolamine (NAE) family. It is an endocannabinoid-like lipid naturally produced by keratinocytes, mast cells, and other immune cells in response to tissue damage and inflammation. First identified by Nobel laureate Rita Levi-Montalcini's group, PEA has well-documented anti-inflammatory, analgesic, and anti-pruritic properties. It acts primarily through peroxisome proliferator-activated receptor alpha (PPAR-α), with additional modulatory effects on the endocannabinoid system via the entourage effect. In dermatology, topical PEA-containing formulations have demonstrated efficacy in reducing pruritus, erythema, and xerosis in atopic dermatitis and other inflammatory dermatoses, with a very favorable safety profile and no known significant adverse effects.
Mechanism of Action
Palmitoylethanolamide exerts its anti-inflammatory and anti-pruritic effects through multiple complementary mechanisms. Its primary target is PPAR-α, a nuclear receptor that, upon activation, transrepresses NF-κB and AP-1 signaling pathways, reducing the transcription of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, IL-8) and chemokines. PEA also modulates mast cell degranulation via an autacoid local injury antagonism (ALIA) mechanism, downregulating the release of histamine, prostaglandins, and nerve growth factor (NGF). Through the entourage effect, PEA enhances the activity of endogenous anandamide (AEA) at CB1 and TRPV1 receptors by inhibiting fatty acid amide hydrolase (FAAH) and competing for intracellular transport, thereby amplifying endocannabinoid-mediated anti-nociceptive and anti-inflammatory signaling. Additionally, PEA supports barrier lipid synthesis by promoting ceramide production in keratinocytes.
Indications
- Atopic dermatitis (anti-pruritic, anti-inflammatory)
- Contact dermatitis
- Xerosis / dry skin with pruritus
- Eczema-associated itch
- Sensitive / reactive skin
- Neuropathic itch
- Mild psoriasis (adjunctive)
- Post-procedural skin calming
Available Concentrations
Side Effects
- Very well tolerated
- No significant adverse effects reported in clinical studies
- Rare mild local irritation
Contraindications
- Known hypersensitivity to palmitoylethanolamide or N-acylethanolamines
Pregnancy Category
Not formally classified (endogenous compound, generally considered safe; limited formal pregnancy studies)